These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1509996)

  • 1. Effects of flecainide on atrial electrophysiology in the Wolff-Parkinson-White syndrome.
    Camm AJ; Katritsis D; Nunain SO
    Am J Cardiol; 1992 Aug; 70(5):33A-37A. PubMed ID: 1509996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome.
    O'Nunain S; Garratt CJ; Linker NJ; Gill J; Ward DE; Camm AJ
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):2028-34. PubMed ID: 1721219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
    Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M
    Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of flecainide on electrophysiological properties of accessory pathways in the Wolff-Parkinson-White syndrome.
    Neuss H; Buss J; Schlepper M; Berthold R; Mitrović V; Krämer A; Musial WJ
    Eur Heart J; 1983 May; 4(5):347-53. PubMed ID: 6617681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
    Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L
    Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
    Ludmer PL; McGowan NE; Antman EM; Friedman PL
    J Am Coll Cardiol; 1987 Jun; 9(6):1357-63. PubMed ID: 3294970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible protective effect of propafenone or flecainide during atrial fibrillation in patients with an accessory atrioventricular connection.
    Auricchio A
    Am Heart J; 1992 Oct; 124(4):932-7. PubMed ID: 1529904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of flecainide acetate in rapid atrial fibrillation complicating Wolff-Parkinson-White syndrome.
    Kappenberger LJ; Fromer MA; Shenasa M; Gloor HO
    Clin Cardiol; 1985 Jun; 8(6):321-6. PubMed ID: 4006340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transesophageal versus intracardiac atrial stimulation in assessing anterograde conduction properties of the accessory pathway in Wolff-Parkinson-White syndrome.
    Favale S; Minafra F; Massari V; Tritto M; Rizzon P
    Int J Cardiol; 1991 Feb; 30(2):209-14. PubMed ID: 2010244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of transesophageal auricular stimulation for evaluating the accessory pathway and effect of treatment in Wolf-Parkinson-White syndrome].
    Kieny JR; Kraenner C; Facello A; Roul G; Mossard JM; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1585-93. PubMed ID: 2510679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic effects of intravenous propafenone in Wolff-Parkinson-White syndrome.
    Dubuc M; Kus T; Campa MA; Lambert C; Rosengarten M; Shenasa M
    Am Heart J; 1989 Feb; 117(2):370-6. PubMed ID: 2644795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flecainide in the Wolff-Parkinson-White syndrome.
    Crozier I
    Am J Cardiol; 1992 Aug; 70(5):26A-32A. PubMed ID: 1509995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length.
    Boahene KA; Klein GJ; Yee R; Sharma AD; Fujimura O
    J Am Coll Cardiol; 1990 Nov; 16(6):1408-14. PubMed ID: 2229793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of flecainide on the rate dependence of atrial refractoriness, atrial repolarization and atrioventricular node conduction in anesthetized dogs.
    O'Hara G; Villemaire C; Talajic M; Nattel S
    J Am Coll Cardiol; 1992 May; 19(6):1335-42. PubMed ID: 1564235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination.
    Biffi M; Boriani G; Bronzetti G; Capucci A; Branzi A; Magnani B
    Heart; 1999 Aug; 82(2):176-82. PubMed ID: 10409531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of efficacy of flecainide in the Wolff-Parkinson-White syndrome after isoproterenol administration.
    Brembilla-Perrot B; Admant P; Le Helloco A; Pernot C
    Eur Heart J; 1985 Dec; 6(12):1074-8. PubMed ID: 3830711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Bonnet P; Scala PJ; Demeyer JF
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
    Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
    G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic and clinical effects of intravenous and oral encainide in patients with Wolff-Parkinson-White syndrome and paroxysmal atrial fibrillation.
    Chimienti M; Moizi M; Salerno JA; Klersy C; Guasti L; Previtali M; Marangoni E; Montemartini C; Bobba P
    Eur Heart J; 1987 Mar; 8(3):282-90. PubMed ID: 3107987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
    Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
    Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.